This study is looking at whether using a Continuous Glucose Monitor (CGM) can help people with diabetes avoid being readmitted to the hospital. If you join, you'll either use the Dexcom G7 CGM, which shares real-time blood sugar data with your healthcare team, or you'll use traditional 'finger stick' tests. Doctors will use this information to make treatment decisions during your scheduled visits. The study aims to see if using a CGM improves blood sugar control, reduces low blood sugar (hypoglycemia) events, and lessens blood sugar variability over 90 days. You might be able to join if you are 18 to 90 years old, have diabetes, are expected to use insulin after leaving the hospital, and have uncontrolled blood sugar (HbA1c of 8% or higher). The current status of this study is unclear, and it plans to enroll 120 participants.

Study design

This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 120 participants and compares two different ways of monitoring blood sugar.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will track changes in your blood sugar control, hypoglycemia events, and glucose variability for 90 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.